NxThera spinout NxPhase lands $10m for vapor ablation tech

NxPhase Medical – spun out of NxThera when Boston Scientific bought it this year– has raised more than $10 million, according to a recent U.S. Securities and Exchange Commission filing.

Maple Grove, Minn.–based NxPhase is focused on using convective thermal water vapor to treat prostate, kidney, and bladder cancer, according to its LinkedIn page. And SEC Form D dated Nov. 29 says it is seeking to raise more than $18 million in its present money-raise.

NxThera’s Rezūm benign prostatic hyperplasia device uses steam to ablate excess prostate tissue. Boston Scientific closed on its $406 million acquisition of NxThera in April. The deal included the spin out of NxPhase, a new company to commercialize technology for treating cancer.

Only a Few More Days to Register for the most anticipated conference of the winter! DeviceTalks West is just a few days away. Join more than 300 of your peers for a day of world-class education, networking, and a technology exhibition featuring the leading companies in the industry. Don’t miss out on this premier opportunity to come together and share perspectives with the best of the best in the industry. REGISTER NOW Use code LASTCHANCE to save an additional 20%.